Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Chubb
Julphar
Cipla
UBS
Farmers Insurance
Cerilliant
Queensland Health
Federal Trade Commission
QuintilesIMS

Generated: August 20, 2017

DrugPatentWatch Database Preview

LASIX Drug Profile

« Back to Dashboard

What is the patent landscape for Lasix, and what generic Lasix alternatives are available?

Lasix is a drug marketed by Sanofi Aventis Us and Us Pharm Holdings and is included in three NDAs.

The generic ingredient in LASIX is furosemide. There are twenty-one drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the furosemide profile page.

Summary for Tradename: LASIX

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list86
Clinical Trials: see list19
Patent Applications: see list7,036
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LASIX at DailyMed

Pharmacology for Tradename: LASIX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
LASIX
furosemide
SOLUTION;ORAL017688-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LASIX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
LASIX
furosemide
SOLUTION;ORAL017688-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Merck
Mallinckrodt
Express Scripts
Farmers Insurance
Cipla
Moodys
Novartis
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot